Aroa Biosurgery Ltd (AU:ARX) has released an update.
Steven Engle, a director at Aroa Biosurgery Limited, has finalized his interest notice with the ASX, declaring cessation from his director role as of March 31, 2024. His disclosed interests include ownership of 859,758 ordinary shares and options for additional shares expiring in 2025 and 2028. There are no interests registered in the name of other holders or interests in contracts reported.
For further insights into AU:ARX stock, check out TipRanks’ Stock Analysis page.
